U.S. Gas Utilities Stock News

Castle Biosciences stock came into the print already on a strong run, with double digit gains over the past month, then jumped another 4.5% to about US$28 after the Q2 release. That kind of move suggests traders see more than just a routine quarter. The headline is simple: Revenue reached US$103.5m and management lifted full year sales guidance, while the income statement still showed a small loss. The market is clearly focusing on the stronger top line and higher outlook more than the loss,...

LKQ stock barely flinched after earnings, slipping about 0.7% to US$22.45, even though the story behind the numbers is heavier than that move suggests. The headline is simple: earnings power is under pressure. Adjusted earnings per share landed at US$0.67 for the quarter while the company cut full year adjusted earnings guidance to US$2.60 to US$2.90 and trimmed its free cash flow outlook. For long term holders, the question now is whether a lower bar on profits and cash generation is a...

On July 30, 2026, activist investor JANA Partners sent a letter to Fiserv’s Board supporting a potential sale of its debit network assets and urging a formal, comprehensive review of the entire portfolio alongside further Board changes to address governance concerns. JANA’s push follows management turnover, what it describes as an earnings reset, and a very large share price decline from 2025 highs, framing a possible turnaround through portfolio divestitures and governance reform as a way...

First Solar stock added 2.4% to about US$211, even after a flat three months, as investors absorbed an earnings release built around one clear story: profitability. The quarter delivered a gross margin of about 57% and trailing net profit margins of 32.5% with net income of US$423 million, which is a notably strong combination for a hardware heavy solar manufacturer. Short term traders are reacting to the headline print. Long term holders are more likely focused on whether this kind of margin...

Mastercard stock slipped about 1% today, a modest pullback for a company that just reported another quarter of strong profits. The market reaction looks cautious rather than panicked. Q2 basic earnings per share came in at about US$4.98 on revenue of US$9.3b, with net income of roughly US$4.4b, which kept profitability firmly in focus. The central story for Mastercard is its profit engine. Net profit margin over the last year sat in the mid 40s, which is uncommon for a global payments...

Alliant Energy stock barely flinched after earnings, slipping about 0.2% on the day, even though the results gave investors more to consider than the price suggests. The company delivered Q2 2026 basic earnings per share of about US$0.66 and net income of US$170 million, numbers that sit within a steady but closely watched profit story. The real story for Alliant Energy is a subtle squeeze. Trailing 12 month earnings are essentially flat and net margin over the past year has eased, while the...

In the second quarter of 2026, Neurocrine Biosciences reported revenue of US$959.0 million and net income of US$144.4 million, with earnings per share rising year over year, while six‑month revenue reached US$1.77 billion and net income US$342.3 million. The company also deepened its leadership bench with new senior appointments in market access, intellectual property, finance, and business development, aligning management capabilities with its broadened commercial portfolio and...

In July 2026, Celanese Corporation reported that the Amsterdam District Court dismissed in full a damages claim by Shell Chemicals Europe B.V. and a separate declaratory liability claim brought by certain Repsol entities via Stichting Ethylene Claims, both linked to follow-on litigation from a 2020 European Commission settlement over past ethylene purchases in North-Western Europe. This legal outcome removes a layer of uncertainty around potential ethylene-related liabilities for Celanese,...

Sirius XM Holdings stock has slipped about 4% to US$29.62 in the first full trading day after earnings, even though the headline numbers were solidly in the black. Q2 net income reached US$239 million with basic earnings per share of US$0.71, and free cash flow surged, helped by tight cost control. In the very short term you are watching a pullback in a stock that had already logged a positive 90 day return. Over a longer horizon the real story is the tension between improving profitability...

Elevance Health (NYSE:ELV) has introduced an enhanced connected cancer care model that uses predictive analytics, certified oncology navigators, and digital tools to tailor support for patients. The program is designed to coordinate care, target avoidable hospitalizations, and provide ongoing assistance throughout the cancer treatment journey. Elevance Health launched this expanded oncology model as its stock traded at $375.84, with a return of 39.7% over the past year and 6.1% year to...

Seagate Technology Holdings (STX) is back in focus after reporting much stronger quarterly and full year results, issuing upbeat fiscal 2027 guidance and highlighting long term demand visibility from AI and cloud customers. See our latest analysis for Seagate Technology Holdings. The strong earnings, dividend affirmation and fresh fiscal 2027 guidance have come on top of a powerful run in Seagate Technology Holdings, with the stock posting a 17.74% 90 day share price return and a very large 1...

In late July, investors focused on Palantir Technologies ahead of its August 3 second-quarter 2026 earnings release, as expectations centered on strong AI-driven revenue growth and heightened U.S. government demand, including its Maven AI system gaining Pentagon program-of-record status. At the same time, questions about commercial adoption, international contract renewals, and how effectively Palantir can convert intense AI interest into sustainable earnings have become increasingly...

Colgate-Palmolive’s second-quarter 2026 results showed sales rising to US$5,361 million from US$5,110 million a year earlier, while net income and earnings per share eased, and the company kept its full-year 2026 outlook for 2% to 6% net sales growth and double-digit GAAP EPS growth. The combination of higher sales but softer profitability, alongside management’s decision to maintain guidance despite ongoing cost and margin pressures, highlights a focus on sustaining growth while absorbing...

Western Union just took a 17% hit, with the stock closing at US$6.36 after its Q2 earnings. That is a sharp move for a mature payments company and indicates the market is focused on near term pain. The main issue is margin pressure. Adjusted earnings per share landed at US$0.31, below last year, and the trailing net profit margin now sits at 9.8% compared with 21.8% a year ago. Short term traders are reacting to that squeeze. Longer term investors are weighing a low P/E near 5x and a double...

Veracyte stock just dropped 22% to US$46.32, even though the quarter delivered what many long term investors say they want. Revenue reached US$150.3m and net income came in at US$25.5m, with adjusted earnings before interest, tax, depreciation and amortization at US$44m, equal to 29.2% of sales. That is a rich margin in diagnostics testing. The short term verdict is clear on your screen. The longer term question is whether a business that now generates this level of profit and cash can...

In the past few days, analysts highlighted Transocean as one of several Energy names seen as well positioned to beat second-quarter 2026 earnings estimates, helped by firm commodity prices and improving offshore drilling conditions. An interesting angle is how Transocean’s potential earnings surprise is being tied to sector-wide operational tailwinds, rather than company-specific news alone, underscoring its sensitivity to broader Energy market conditions. We’ll now examine how this...

In late July 2026, Hims & Hers Health responded to a lawsuit from the Federal Trade Commission, Utah, and Los Angeles County alleging deceptive subscription practices and improper sharing of sensitive patient data with advertising platforms, firmly rejecting the claims and vowing to defend its telehealth business model and privacy practices. The company argues the case ignores industry norms and its consent-based data policies, framing the action as headline-driven rather than...

GATX stock slipped about 1.6% to US$178.87 after its latest results, even as the quarter delivered one of the strongest earnings jumps investors have seen from this railcar lessor in recent years. Diluted earnings per share reached US$2.84 in Q2, helped by sizeable gains on railcar sales and a solid contribution from the Wells Fargo Rail acquisition. The immediate share price move indicates a cautious short term reaction. However, the raised full year earnings guidance, now pointing to...

Cerus stock just absorbed a hit, sliding about 26% to US$2.15 after its latest earnings, even though the company reported another quarter of double digit product revenue growth and nudged full year guidance higher. The headline is not a collapse in demand. The headline is a profit story that still sits in the red and a margin profile under pressure, with product gross margin at 51.4%. For short term traders the selloff is the story. For longer term investors the key question is how that...

Saia stock eased 0.9% to about US$347 after the Q2 earnings release, extending a weak stretch over the past month and quarter. That move understates how powerful this quarter was on the ground. Revenue reached a record US$956.5m and diluted earnings per share were US$3.51, supported by an improved operating ratio, the key profit gauge in less than truckload freight. The short term trading action is soft. The bigger story is a carrier beginning to translate years of network and technology...

United States Lime & Minerals stock slipped about 2% today, yet the headline from this quarter is not weakness. The company printed one of its cleanest profit pictures, with Q2 net income of US$34.51 million on revenue of US$99.13 million, keeping net margins in the mid 30s. For a lime and minerals producer that lives and dies on cost control and pricing power, that margin resilience is the real story. The market seems to be focusing more on a P/E of 23.5x than on the earnings strength it is...

Baldwin Insurance Group stock jumped about 4% to US$27.74 after the Q2 print, a sharp move for a broker that many investors still file under a long term turnaround story. The headline is not the GAAP loss of US$39 million or basic earnings per share of US$0.42 in the red. What lit up the tape was the strength in the core engine, with revenue of US$492.9 million and adjusted earnings before interest, tax, depreciation and amortization showing a firm margin profile that supports the recovery...

FTI Consulting stock slipped about 3% to roughly US$159 after its Q2 print, even though the headline numbers looked solid on the surface. Revenue landed just under US$1b with basic earnings per share a little above US$2. The friction came from profitability. Management cut full year GAAP earnings guidance and flagged higher selling, general and administrative costs, including heavier legal spend. In the very short term that pressures the story. For investors thinking in years rather than...

KLA (KLAC) is back in focus after reporting fourth quarter and full year 2026 results, issuing new quarterly guidance, and highlighting advanced packaging demand related to AI chip complexity and process control tools. See our latest analysis for KLA. KLA’s recent earnings beat, upbeat guidance and comments on AI driven packaging have arrived after a sharp reset in momentum. The 30 day share price return is down 31.32%, yet the year to date share price return of 43.45% and the 1 year total...